Renaissance Technologies - XERIS PHARMACEUTICALS INC ownership

XERIS PHARMACEUTICALS INC's ticker is XERS and the CUSIP is 98422L107. A total of 54 filers reported holding XERIS PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of XERIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$348,000
-93.1%
142,012
-88.5%
0.00%
-100.0%
Q2 2021$5,033,000
+5.5%
1,236,595
+16.9%
0.01%0.0%
Q1 2021$4,770,000
+846.4%
1,057,663
+933.4%
0.01%
+500.0%
Q4 2020$504,000
+30.6%
102,349
+57.2%
0.00%
Q3 2020$386,000
+38.4%
65,095
-38.0%
0.00%
Q2 2020$279,000
-63.1%
105,000
-72.9%
0.00%
-100.0%
Q1 2020$756,000
+236.0%
387,516
+1867.1%
0.00%
Q2 2019$225,00019,7000.00%
Other shareholders
XERIS PHARMACEUTICALS INC shareholders Q3 2019
NameSharesValueWeighting ↓
Sessa Capital IM, L.P. 4,172,459$20,528,0001.31%
DELTEC ASSET MANAGEMENT LLC 693,870$3,414,0000.52%
Alpine Global Management, LLC 350,000$1,722,0000.35%
Redmile Group, LLC 2,397,441$11,795,0000.14%
Kamunting Street Capital Management, L.P. 43,833$216,0000.11%
IHT Wealth Management, LLC 250,798$1,234,0000.10%
SEARLE & CO. 34,000$167,0000.08%
GPS Wealth Strategies Group, LLC 46,025$226,0000.08%
ArrowMark Colorado Holdings LLC 1,981,909$9,751,0000.08%
Gladstone Institutional Advisory LLC 51,500$2530.05%
View complete list of XERIS PHARMACEUTICALS INC shareholders